PubMed · 14408491
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
J KENEZ, E SZASZI. 1960. [Experiences with cycloserine therapy].. https://pubmed.ncbi.nlm.nih.gov/14408491/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
D-Cycloserine (DCS) is a peptidoglycan inhibitor. Although very effective against Mycobacterium tuberculosis, it is seldom employed in the management of this infection due to its high toxicity. beta-Chloro-D-alanine (another peptidoglycan inhibitor) reduces the MIC of DCS from 50 to 2.5 mg/L at a concentration significantly below its MIC for this organism. A reduction in bacterial viability and significant growth inhibition (as quantified by the X/Y quotient for the Bactec radiometric procedure) were observed with subinhibitory concentrations of both drugs. It is suggested that this powerful synergic effect should be the object of in vivo and eventually clinical trials.
Explore the source record for details and available documents.
Explore the source record for details and available documents.